Overview

The Effects

Treatment Options

Treatment Options

Supportive Care: 

Blood pressure management with fluids or vasopressors.

Antidote: 

Administration of naloxone to reverse opioid effects, multiple naloxone doses or continuous infusion may be required due to sufentanil’s potency.

Pharmacokinetics and Dynamics

Metabolism: 

Sufentanil is metabolized primarily by the liver and enterocytes of the small intestine, with metabolism catalyzed by the cytochrome P450 enzyme system, mainly CYP3A4. Due to its extensive first-pass metabolism in the gastrointestinal (GI) tract, oral bioavailability is extremely low, making non-IV administration ineffective.

​

Sufentanil follows linear pharmacokinetics within the studied dose range, meaning its elimination rate remains proportional to the administered dose. Approximately 80% of the administered dose is eliminated within 24 hours, primarily through urinary excretion of metabolites.

Drug-Drug Interactions: 

Sufentanil interacts strongly with CNS depressants, benzodiazepines (e.g., midazolam, diazepam) increase sedation and respiratory depression, other opioids enhance its effects, increasing overdose risk, general anesthetics (e.g., propofol, sevoflurane) have additive effects on sedation and hypotension, MAOIs can cause unpredictable cardiovascular effects, neuromuscular blockers can increase muscle rigidity.